((8R,9S,10R,13S,14S,17R)-17-(2-HYDROXYACETYL)-10,13-DIMETHYL-3-OXO-7,8,9,11,12,14,15,16-OCTAHYDRO-6H-CYCLOPENTA(A)PHENANTHREN-17-YL) PROPANOATE
UNII ZU9V52BQ5A
Substance Identification & Data
This profile provides standardized clinical and technical data for ((8r,9s,10r,13s,14s,17r)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta(a)phenanthren-17-yl) Propanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZU9V52BQ5A.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H32O5 CWKOLUNMBMOUGL-PDUMRIMRSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for ((8r,9s,10r,13s,14s,17r)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta(a)phenanthren-17-yl) Propanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.